chr11-247283-A-G
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_002817.4(PSMD13):āc.403A>Gā(p.Ile135Val) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000323 in 1,611,452 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_002817.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
PSMD13 | NM_002817.4 | c.403A>G | p.Ile135Val | missense_variant | 7/13 | ENST00000532097.6 | |
PSMD13 | NM_175932.3 | c.409A>G | p.Ile137Val | missense_variant | 5/11 | ||
PSMD13 | XM_011520235.4 | c.403A>G | p.Ile135Val | missense_variant | 7/11 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
PSMD13 | ENST00000532097.6 | c.403A>G | p.Ile135Val | missense_variant | 7/13 | 1 | NM_002817.4 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000145 AC: 22AN: 152216Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000242 AC: 6AN: 248258Hom.: 0 AF XY: 0.0000298 AC XY: 4AN XY: 134232
GnomAD4 exome AF: 0.0000206 AC: 30AN: 1459118Hom.: 0 Cov.: 31 AF XY: 0.0000179 AC XY: 13AN XY: 725776
GnomAD4 genome AF: 0.000144 AC: 22AN: 152334Hom.: 0 Cov.: 33 AF XY: 0.000161 AC XY: 12AN XY: 74490
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 18, 2023 | The c.409A>G (p.I137V) alteration is located in exon 5 (coding exon 5) of the PSMD13 gene. This alteration results from a A to G substitution at nucleotide position 409, causing the isoleucine (I) at amino acid position 137 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at